RT Journal Article
SR Electronic
T1 Bowel ischaemia in COVID-19 infection: a scoping review protocol
JF BMJ Open
JO BMJ Open
FD British Medical Journal Publishing Group
SP e060566
DO 10.1136/bmjopen-2021-060566
VO 12
IS 9
A1 Zhao, Yi
A1 Teh, Jhia Jiat
A1 Kung, Victor
A1 Mallappa, Sreelakshmi
YR 2022
UL http://bmjopen.bmj.com/content/12/9/e060566.abstract
AB Introduction COVID-19 disease was declared as a pandemic by WHO since March 2020 and can have a myriad of clinical presentations affecting various organ systems. Patients with COVID-19 are known to have an increased risk of thromboembolism, including cardiovascular, pulmonary and cerebral ischaemic events. However, an increasing number of case studies have reported that COVID-19 infection is also associated with gastrointestinal ischaemia. This scoping review aims to collate the current evidence of COVID-19-related gastrointestinal ischaemia and raise awareness among healthcare professionals of this lesser known, but serious, non-pulmonary complication of COVID-19 infection.Methods The proposed scoping review will be conducted as per the Arksey and O’Malley methodological framework (2005) the Joanna Briggs Institute methodology for scoping reviews. A systematic search will be undertaken on different databases including EMBASE, PubMed and MEDLINE. Two independent reviewers will screen titles, abstracts and full-text articles according to the inclusion criteria and extract relevant data from the included articles. Results will be presented in a tabular form with a narrative discussion.Ethics and dissemination Ethical approval will not be required for this scoping review. This scoping review will provide an extensive overview of the association between COVID-19 infection and bowel ischaemia. Further ethical and methodological challenges will also be discussed in our findings to define a new research agenda. Findings will be disseminated through peer-reviewed publications and presentations at both national and international conferences.